Solasto Corp operates in the Home health care services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solasto Corp with three other
health care providers in Asia:
Fureasu Co Ltd
sales of 3.96 billion Japanese Yen [US$36.85 million]
of which 92%
Nichiigakkan Co Ltd
(297.97 billion Japanese Yen [US$2.77 billion]
Care Service Company Ltd
(9.06 billion Japanese Yen [US$84.22 million]
Solasto Corp reported sales of ¥95.72 billion (US$890.19 million)
March of 2020.
increase of 13.6%
versus 2019, when the company's sales were ¥84.25 billion.
Sales at Solasto Corp have increased during each of the previous five years
(and since 2015, sales have increased a total of 59%).